Table:
begin	end	state
1	26	cytoplasmic
27	52	transmembrane
53	59	non-cytoplasmic
60	80	transmembrane
81	91	cytoplasmic
92	113	transmembrane
114	159	non-cytoplasmic
160	183	transmembrane
184	194	cytoplasmic
195	215	transmembrane
216	244	non-cytoplasmic
245	265	transmembrane
266	284	cytoplasmic
285	310	transmembrane
311	329	non-cytoplasmic
330	352	transmembrane
353	382	cytoplasmic
383	402	transmembrane
403	407	non-cytoplasmic
408	427	transmembrane
428	438	cytoplasmic
439	460	transmembrane
461	465	non-cytoplasmic
466	483	transmembrane
484	495	cytoplasmic

Input:
>NP_661816.1 NCBI__GCF_000006985.1:NP_661816.1
MKNSFRKKPLSLLLEEMKSEHRLNRVLGPLALTSLGVGAIIGTGIFVLIGVAAHDKAGPA
VTLSFALAGLACVFAALCYAEFASMAPVAGSAYTYAYATLGELFAWIIGWDLILEYAVAS
ATVAHGWSHYFQDFMGIFGLHIPEIFSRAPLDFDPATGSLVLTGSMFDLPAVIIVLIVTV
ILVKGIRESAGFNTAMVIVKVAIVLLVIVLGAQYVKPENWQPFAPFGYSGLSVFGHTILG
ETGAGGAPVGVLAGAAMIFFAYIGFDSISTHAEEARRPERDVPIGIIASLIICTMLYVAV
AAVITGMVPYDQINIDAPVSYAFKQVGLDWAQFLVSLGAITGITSVLLVMMLSQPRIFLA
MARDGLLPNKFFGVVHPKFKTPWNATILTGIFVAILGAFLPLRLLAELVNIGTLFAFVVV
CAAVLIMRRTNPDAERPFRAPLVPFVPIAGILTCLLLMFSLPAENWWRLIVWLLIGFCIY
FFYGRHHSVLNQHHD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server